Not Signed In -
Biliary Tract Diseases |
|
|
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Clinical Trial: Biliary Atresia Research Consortium
This study is currently recruiting patients.
Purpose
Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary Atresia Research Consortium (BARC) is to establish a database of clinical information and serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal hepatitis (INH) to facilitate research and to perform clinical, epidemiological and therapeutic trials in these two important pediatric liver diseases.
| Condition |
|---|
| Biliary Atresia Cholestasis |
MedlinePlus related topics: Bile Duct Diseases; Birth Defects; Digestive Diseases
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Eligibility
Ages Eligible for Study: up to 6 Months, Genders Eligible for Study: Both
Criteria
- Age less or equal to 180 days at presentation to clinical site.
- Clinically meaningful cholestasis due to primary hepatobiliary disease.
Location and Contact Information
California
University of California, San Francisco, California, 94143, United States; Recruiting
Philip Rosenthal, MD, Principal Investigator
Colorado
The Children's Hospital, Denver, Colorado, 80218, United States; Recruiting
Ronald Sokol, MD, Principal Investigator
Cara Mack, MD, Sub-Investigator
Michael Narkewicz, MD, Sub-Investigator
Illinois
Children's Memorial Hospital, Chicago, Illinois, 60614, United States; Recruiting
Peter Whitington, MD, Principal Investigator
Maryland
Johns Hopkins School of Medicine, Baltimore, Maryland, 21287, United States; Recruiting
Kathleen Schwarz, MD, Principal Investigator
Patricia DeRusso, MD, Sub-Investigator
Missouri
Washington University School of Medicine, St. Louis, Missouri, 63110, United States; Recruiting
Robert Heukeroth, MD, Sub-Investigator
New York
Mount Sinai Medical Center, New York City, New York, 10029, United States; Recruiting
Benjamin Shneider, MD, Principal Investigator
Ohio
Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States; Recruiting
Jorge Bezerra, MD, Principal Investigator
John Bucuvalas, MD, Sub-Investigator
Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States; Recruiting
Barbara Haber, MD, Principal Investigator
Elizabeth Rand, MD, Sub-Investigator
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States; Recruiting
David Perlmutter, MD, Principal Investigator
Ronald Sokol, MD, Study Chair, The Children's Hospital, Denver
Patricia Robuck, PhD, Study Director, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Morton B Brown, PhD, Study Director, University of Michigan, Ann Arbor
More Information
Biliary Atresia Research Consortium website
Record last reviewed: January 2005
Last Updated: January 7, 2005
Record first received: June 5, 2003
ClinicalTrials.gov Identifier: NCT00061828
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
email this page
print this page
bookmark this page
feedback on this page
